Tabla de Contenidos: “…Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population -- Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study -- Prevalence of HCV genotypes in Poland - the EpiTer study -- Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases -- The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin -- The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation…”